U.S. National Institutes of Health's (NIH's) Small Business Innovation Research (SBIR) award program. Based on this …

Innovation policy can be a crucial component of governments' responses to crises. Because speed is a paramount … objective, crisis innovation may also require different policy tools than innovation policy in non-crisis times, raising … distinct questions and tradeoffs. In this paper, we survey the U.S. policy response to two crises where innovation was crucial …

Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …

-produced penicillin, antimalarials, and a flu vaccine. We draw on this episode to discuss the economics of crisis innovation. Since the …

pharmaceutical patent protection alone does not stimulate domestic innovation, as estimated by the US patent awards (both raw counts … innovation acceleration and technology transfer, conditional upon certain country variables. In particular, the interaction …Research on the effects of patent protection on innovation and technology transfer in the cross-country pharmaceutical …